THE ADVISORY AGREEMENTTermination Agreement • June 26th, 2024 • Elevai Labs Inc. • Pharmaceutical preparations
Contract Type FiledJune 26th, 2024 Company IndustryThis Termination Agreement is dated as of June 21, 2024 (the “Termination Agreement”), by and between Braeden Lichti (“Advisor”), and Elevai Labs Inc., a Delaware corporation (the “Company”, together the “Parties”, and each, a “Party”).
AMENDED AND RESTATED CONSULTING AGREEMENT FOR NON-EXECUTIVE CHAIRMANConsulting Agreement • June 26th, 2024 • Elevai Labs Inc. • Pharmaceutical preparations • California
Contract Type FiledJune 26th, 2024 Company Industry JurisdictionThis Amended and Restated Consulting Agreement (this “Agreement”), effective as of June 21, 2024 (“Effective Date”), is entered into by and between Elevai Labs Inc., a Delaware corporation fka Reactive Medical Labs, Inc. (“Company”), and NorthStrive Companies Inc., a California corporation (“Consultant”).
AMENDED AND RESTATED CONSULTING AGREEMENT FOR NON-EMPLOYEE CHIEF EXECUTIVE OFFICERConsulting Agreement • June 26th, 2024 • Elevai Labs Inc. • Pharmaceutical preparations • California
Contract Type FiledJune 26th, 2024 Company Industry JurisdictionThis Amended and Restated Consulting Agreement (this “Agreement”), effective as of June 21, 2024 (“Effective Date”), is entered into by and between Elevai Labs Inc., a Delaware corporation fka Reactive Medical Labs, Inc. (“Company”), and GB Capital Ltd, a British Columbia, Canada Corporation (“Consultant”).